Unigene Laboratories, Inc. (UGNE.OB) Expands Leadership Team to Support Peptide Therapeutics Development
Unigene Laboratories, www.unigene.com – a leader in the burgeoning field of peptide-based therapeutics which is aggressively building a robust portfolio of partnerships via its sophisticated Peptelligence™ platform, reported today the expansion of its leadership team (effectively immediately) with the appointment of Gregory T. Mayes to the newly created position of Vice President, Corporate Affairs and General Counsel. Subsequently Roxanne Tavakkol was promoted to the position of VP, Global Regulatory Affairs and both of these appointments will report directly President and CEO, Ashleigh Palmer. This more robust leadership profile will help the Company to fully leverage its Peptelligence platform’s assets which…